undergo PCI within 90 minutes of FMC, should be treated with fibrinolytic therapy within 30 minutes of hospital presentation, unless such therapy is contraindicated.
INTRODUCTION

South African cardiologists frequently encounter patients with
ST-segment elevation myocardial infarction (STEMI). Not infrequently, patients present for medical care long after the onset of symptoms and without having received any prior reperfusion therapy. There is no standardised management protocol for the management of STEMI in the public or private sector. The key objectives of the SA Heart STEMI Early Reperfusion Project are to improve quality of acute myocardial infarction (AMI) care and to improve the care network to ensure prompt access to reperfusion therapy and decrease mortality from AMI.
These objectives accord with the European Society of
Cardiology's (ESC) Stent for Life programme to promote the implementation of their guidelines in the management of AMI and to identify the specific barriers to their implementation. A further objective is to formulate key actions to ensure that the majority of STEMI patients have access to primary percutaneous coronary intervention (p-PCI) within 120 minutes. (1) According to the ESC guidelines, (1) it is a CLASS 1 A recommendation that STEMI patients presenting to a hospital with PCI capability should be treated with primary PCI within 90 minutes of first medical contact (FMC), while it is a CLASS 1 B recommendation that STEMI patients presenting to a hospital without PCI capability, and who cannot be transferred to a PCI center and Adriaan Snyders * and Rhena Delport # Autumn 2015 Volume 12 • Number 2 essary case fatalities. (3, 4) Ideally patients should have access to a referral pathway to p-PCI that is managed by informed professionals and is free of delays and bottlenecks. Patient, system and other delays contribute to the inability to meet quality targets. (4) (5) (6) Factors contributing to extended referral pathways, such as cath lab activation times and door-to-balloon time, need to be identified and specifically targeted to ensure improved patient outcomes.
The SA Heart Association performed this pilot survey to investigate which factors contribute to ineffective management 
RESULTS
Ten patients were attended to by a physician prior to admission, five of whom were DA cases and five IFT cases. Two IFT patients died during PCI, one female and one male. The 24 IFT patients, whose FMC was an emergency physician at a non-PIC facility, were referred to a PCI-capable hospital for further treatment. The risk profiles of the referral pathway groups were similar although patients previously diagnosed with myocardial ischaemic events appeared more likely to follow the direct access route (Table 1 ).
Significant patient delays (delay between symptom onset and FMC) were evident in both referral groups (Table 2 ) but did not differ significantly between referral groups. Excessive system delays (delay between FMC and admission to cath lab) were also observed in both groups, with significantly longer delays for IFT patients compared to DA patients. FMC did not occur within 120 minutes in 45% and 68% of DA and IFT patients respectively. The treatment goal of performing p-PCI in ≤60 and 90 minutes from FMC was achieved only in DA patients in 13% and 22% respectively.
Ninety-six percent of DA patients and 72% of IFT patients had received fibrinolytics (Table 3 ) and although the 2 groups did not differ significantly with regards to the time lapse between FMC and administration of fibrinolytics, the treatment goal of administering fibrinolytics in ≤30 minutes from FMC was only achieved in 50% of DA and 20% of IFT patients (Table 2) . Table 3 presents information on the different types of fibrinolytics that were administered pre-and post-admission to a PCI-capable hospital.
Reperfusion delays of more than 12 hours from symptom onset were explained by patients delays (duration to FMC dichotomised as ≤/>120 minutes of symptom onset) (Odds ratio 16.5; 95% CI 3.0-91.8), independent of referral pathway THE SA HEART STEMI EARLY INTERVENTION PROJECT ■ There have been instances in which, although the patient was delivered to a PCI-capable facility, transfer to another facility was mandated by the patient's insurer, resulting in needless delays.
DISCUSSION
In broad terms, this small observational study provides the outline on which a national survey can be planned. Significant patient and system delays were evident in both referral groups, and in particular in the IFT group (Table 2, Figure 1) , with the excessive system delays compounding the risk in a significant number of patients whose FMC was beyond 120 minutes of symptom onset. Time lapses between FMC /non-PCI-capable hospitals and PCI-capable hospitals were unnecessarily long and partially explain why 30% of DA and 65% of IFT patients failed to receive timely reperfusion. Patient reaction times suggest that they were uninformed regarding possible symptoms, the importance of timely treatment and the importance of being treated in a PCI-capable hospital. Upon analysis of the South Africa Heart Association registry data, Shamroth, et al. (2) reported median (IQ range) time intervals of 3.6 (1.6; 9.5) hours between the onset of symptoms and arrival at a hospital in a population in which 64% of patients lived within a 30-minute drive from the admitting hospital. The longer time intervals reported in our study may reflect the longer distances patients need to travel from referral hospitals to PCI-capable facilities.
Although the pharmaco-invasive strategy is advocated for STEMI patients living in remote areas with no ready access to PCI facilities, only 65% of IFT patients received a fibrinolytic agent and treatment was delayed until admission to a PCI facility in four of the 23 patients. In addition, fibrinolysis was performed at a median time of four hours and 34 minutes (range 00:02-09:09 hrs:min), well beyond the recommended limit of ≤30 minutes. (1) Difficulty in diagnosing STEMI in IFT patients has been reported previously and has been ascribed to symptoms and early ECG changes being less clear in this cohort of patients. (6) The authors suggest that "initial triage to a non-primary PCI center may be justifiable due to diagnostic uncertainty, and that guideline time metrics should be amended appropriately". (6) However, IFT due to misdiagnosis is associated with significantly higher 1-year mortality.
A recent retrospective study in Cape Town (2008 -2010) reported a median "door-to-needle" time of 54 minutes (range 13 -553 minutes). (9) A fibrinolytic agent was administered in only 44.7% of cases despite 88.8% typical symptoms of myocardial infarction. A "door-to-needle" time of 30 minutes or less was achieved in 33 (20.5%) patients; 51.3% of these patients arrived by ambulance; 34% had a pre-hospital 12-lead ECG. These deviations from recommended practice were ascribed to a lack of senior doctors, difficulty interpreting ECGs, atypical presentations and delays in emergency centers.
Of note, 51.3% of the patients enrolled for this study were transported by ambulance and a 12-lead ECG was performed pre-hospital in 34% of patients. (9) "Time to treatment" and "door-to-balloon" time are both significant determinants of mortality in STEMI. (4) Total time delays to reperfusion therapy by PCI of approximately eight hours for DA patients and 56 hours for IFT patients were observed in this study, and "door-to-balloon" time of ≤90 minutes was only achieved in 22% of DA and 33% of IFT patients. Of concern is that only 22% of DA and none of Inter-facility transfer (n=21) the IFT patients received p-PCI within 90 minutes of FMC.
System delays with DA need to be scrutinised in particular in national follow-up studies for targeted intervention to optimise outcome in this referral group.
Findings relating to Emergency Medical Service (EMS) provision
The scope of practice of emergency care providers for the different levels of training is as follows: (10) ■ A Basic Ambulance Assistant (BAA) provides basic life support and is able to administer oxygen and interpret vital signs. They do not have access to any medication, nor may they administer drugs. They are unable to attach or interpret an ECG. Solutions need to be found for the immediate transmission of the ECG to a control center for early diagnosis and appropriate referral of the patient. All paramedics should be adequately trained to make the "time-sensitive" diagnosis of STEMI and triage the patients successfully as this has the potential to have major impact on patient outcome. (11) Ideally EMS should be mandated to promptly activate the cath lab team. (12) The finding that EMS is not routinely solicited by the public prompts urgent implementation of public awareness initiatives.
FUTURE STRATEGIES
Strategy to establish functional regions
The goals to be attained within the next 24 months are defined as follows: The patient awareness programme needs to be prioritised, based on the finding of this pilot study that risk for missing the treatment goal for reperfusion <12 hours duration of symptom onset increases seventeen-fold if duration to FMC exceeds 120 minutes of symptom onset, independent of referral pathway.
Following this strategy it is hoped that concerted action amongst the role players will ensure early reperfusion by appropriate intervention and that the DA strategy will be followed whenever possible.
THE SA HEART STEMI EARLY INTERVENTION PROJECT
Autumn 2015
Volume 12 • Number 2
STEMI management algorithm
This simple algorithm has been developed to facilitate effective STEMI management (Figure 2 ).
In essence, time to treatment is critical during the first two to three hours after symptom onset. Therefore, anti-platelet therapy and immediate p-PCI is favoured within the first two hours following onset of pain. After 3 hours p-PCI is preferred if it can be performed within 2 hours of FMC. If this is not possible, an immediate pharmacoinvasive strategy with fibrinolysis followed by transfer for PCI within the next 3 to 24 hours is recommended because late reperfusion may improve myocardial salvage and survival. Immediate or "rescue" PCI should be performed for failed reperfusion after fibrinolysis.
Lack of first-line treatment of STEMI with Aspirin is of specific concern, especially with inter-facility transfer of patients, as is evident from this pilot study (Table 3) , and needs to be addressed. Furthermore, the choice of fibrinolytic agent is important to ensure effective reperfusion and there is a need to replace streptokinase in the public sector with a fibrinspecific agent.
Additional considerations
No single practitioner working in isolation can alter outcomes, as evidenced by results from abroad. (7) We hope to establish an effective network between the various stakeholders and create a fully functional central hub that oversees all initiatives and monitors progress through the maintenance of a registry. The mismatch between need and availability of PCI-capable facilities remains a concern (7) but success stories relating to government involvement in other countries are encouraging. (7, 13, 14) Perceived South African healthcare challenges (personal observations) that need to be considered relate to: lessons learnt from other countries are encouraging (7) and much may be learnt from their experiences in treating patients coming from remote areas. 
